Ozanezumab
Ozanezumab is a monoclonal antibody designed for the treatment of ALS, also known as Lou Gehrig's disease. It was developed by GlaxoSmithKline, a British multinational pharmaceutical company.
Mechanism of Action
Ozanezumab works by targeting a protein called Nogo-A, which is found in high levels in the brain and spinal cord of patients with ALS. Nogo-A is believed to inhibit the growth and repair of nerve cells. By blocking the action of Nogo-A, Ozanezumab may help to slow the progression of ALS.
Clinical Trials
Ozanezumab has undergone Phase II clinical trials to evaluate its safety and efficacy in patients with ALS. The results of these trials have been mixed, with some studies showing a slowing of disease progression and others showing no significant effect.
Potential Side Effects
As with all medications, Ozanezumab has the potential to cause side effects. These may include allergic reactions, infections, and changes in liver function. Patients should be closely monitored while receiving this medication.
Future Research
While the results of clinical trials have been mixed, further research is needed to fully understand the potential benefits and risks of Ozanezumab. This includes ongoing studies to determine the optimal dosage and treatment schedule, as well as studies to explore its potential use in other neurological disorders.
See Also
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
